The hazards of comparative effectiveness when we cannot effectively compare

JACC: Cardiovascular Interventions

Volumn 4, Issue 9, 2011, Pages 1028-1029

  Lange, Richard A ^a   Hillis, L David ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

comparative effectiveness; coronary bypass; left main disease; risk factors; stents

Indexed keywords

ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 80052983617     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.07.009     Document Type: Editorial

References (5)

1. AHRQ What is Comparative Effectiveness Research http://www. effectivehealthcare.ahrq.gov/index.cfm/what-is-comparative-effectiveness- research1/ 2011 Accessed July 13, 2011
2. V.J. Bufalino, F.A. Masoudi, and S.K. Stranne The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association Circulation 123 2011 2167 2179
3. E.J. McNulty, W. Ng, and J.A. Spertus Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies J Am Coll Cardiol Intv 4 2011 1020 1027
4. P.S. Chan, M.R. Patel, and L.W. Klein Appropriateness of percutaneous coronary intervention JAMA 306 2011 53 61
5. A.P. Amin, S.P. Marso, and S.V. Rao Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding Circ Cardiovasc Qual Outcomes 3 2010 358 365